Juan P. de-Torres, Bartolome R. Celli
European Respiratory Journal 2022 60: 2201294; DOI: 10.1183/13993003.01294-2022
Extract
Lung cancer and COPD are highly prevalent smoking-related conditions associated with a high burden of morbidity and mortality worldwide [1]. Unfortunately, the diagnosis of these two diseases is strongly associated with the presence of symptoms, which usually makes the diagnosis of lung cancer occur at late, non-curative stages [2], and diagnosis of COPD occur at an older age and advanced dysfunctional condition [3]. Although tobacco smoking is the most important and most studied risk factor for both diseases, the presence of COPD has also been identified as an independent risk factor for lung cancer development [4–7].
Performing a “lung health check” could help tackle COPD and lung cancer at an earlier stage https://bit.ly/3AAKOCu
Footnotes
-
Conflict of interest: J.P. de-Torres declares no competing interests. B.R. Celli declares personal fees from GlaxoSmithKline in support of the present article; as well as consulting fees from AstraZeneca, GlaxoSmithKline, Boehringer Ingelheim, Novartis, Sanofi-Aventis and Menarini, all in the 36 months prior to manuscript submission.
- Received June 25, 2022.
- Accepted July 5, 2022.
- Copyright ©The authors 2022. For reproduction rights and permissions contact permissions@ersnet.org
